Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma.

@article{Lin2017GenomicAE,
  title={Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma.},
  author={Dechen Lin and A. Mayakonda and Huy Q. Dinh and P. Huang and Le-hang Lin and X. Liu and Lingwen Ding and Jiayin Wang and B. Berman and Erwei Song and D. Yin and H. Koeffler},
  journal={Cancer research},
  year={2017},
  volume={77 9},
  pages={
          2255-2265
        }
}
  • Dechen Lin, A. Mayakonda, +9 authors H. Koeffler
  • Published 2017
  • Medicine, Biology
  • Cancer research
  • Understanding the intratumoral heterogeneity of hepatocellular carcinoma is instructive for developing personalized therapy and identifying molecular biomarkers. Here we applied whole-exome sequencing to 69 samples from 11 patients to resolve the genetic architecture of subclonal diversification. Spatial genomic diversity was found in all 11 hepatocellular carcinoma cases, with 29% of driver mutations being heterogeneous, including TERT, ARID1A, NOTCH2, and STAG2. Similar with other cancer… CONTINUE READING

    Figures and Topics from this paper.

    Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia
    • 116
    • Highly Influenced
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 69 REFERENCES
    Signatures of mutational processes in human cancer
    • 4,975
    • PDF
    Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets
    • 726
    • Highly Influential
    • PDF
    Absolute quantification of somatic DNA alterations in human cancer
    • 1,053
    • PDF
    Subclonal diversification of primary breast cancer revealed by multiregion sequencing
    • 470
    • PDF
    Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia
    • 1,022
    • PDF
    Pan-cancer patterns of somatic copy-number alteration
    • 1,128
    • PDF